| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/2010 | US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 09/07/2010 | US7790702 Protein or hydrolyzate/phospholipid complex; used to improve lipid metabolism; functional food comprising the complex; anticholesterol agents |
| 09/07/2010 | US7790687 Treatment for neurodegeneration |
| 09/07/2010 | US7790686 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 09/07/2010 | US7790685 administering a composition comprising placental alkaline phosphatase and alpha 1-antitrypsin and/or transferrin in combination to enhance the cell proliferation, tissue regeneration |
| 09/07/2010 | US7790684 Method of inhibiting osteoclast activity |
| 09/07/2010 | US7790683 Modulation body weights; dietetics; eating disorders; polypeptide having specific amino acid sequence; utilization of D-isoform amino acid substituted leptin-like polypeptides for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass |
| 09/07/2010 | US7790682 Use in tissue engineering, tissue repair; stimulating mitogenesis in cells |
| 09/07/2010 | US7790681 Binding to receptor of glucagon-like peptide; congestive heart failure |
| 09/07/2010 | US7790680 Hemophilia biodrug recombinant porcine factor 8 formulation with replacement for albumin stabilizer, which may carry risk of prions; surfactant such as polysorbate, calcium chloride, sucrose, sodium chloride, trisodium citrate, and a buffer devoid of amino acids |
| 09/07/2010 | US7790679 Pharmaceutical formulations |
| 09/07/2010 | US7790678 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use |
| 09/07/2010 | US7790677 Insulin production methods and pro-insulin constructs |
| 09/07/2010 | US7790676 Soluble IL-17RA/RC fusion proteins |
| 09/07/2010 | US7790675 Using erythropoietin as modulator of frataxin induction; treating neurodegenerative and cell proliferative disorders |
| 09/07/2010 | US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT |
| 09/07/2010 | US7790672 Method of using lectins for prevention and treatment of oral and alimentary tract disorders |
| 09/07/2010 | US7790671 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 09/07/2010 | US7790670 Mixture of milk , protein such as casein and enzyme inhibing peptides |
| 09/07/2010 | US7790669 Parkinson's disease, Alzheimer's disease or Huntington's disease or a neurological injury that results from ischemia such as a stroke; tissue repair |
| 09/07/2010 | US7790454 Administering a translation product of a nucleic acid sequence, high mobility group proteins, HMGI gene |
| 09/07/2010 | US7790433 Using anabaena variabilis ammonia lyase variant as therapeutic in treatment of cell proliferative disorders; antitumor agents |
| 09/07/2010 | US7790419 Antiviral vectors |
| 09/07/2010 | US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
| 09/07/2010 | US7790209 comprising proteins, sugars, fats, minerals and vitamins, with copper content of 0.09 to 0.15 mg, zinc content of 1.5 to 3.0 mg, zinc/copper weight ratio of 10/1-25/1, sodium content of 185 mg or greater, vitamin B1 content of 0.30 mg or greater and vitamin B2 content of 0.25 mg; for elderly, inpatients |
| 09/07/2010 | US7790204 Use of an agent that restores tissue perfusion and oxygenation |
| 09/07/2010 | US7790189 Triple helical oligonucleotide comprising polysaccharide carrier and unmethylated CpG motif for use as DNA vaccine in treatment of infection and metabolic disorders |
| 09/07/2010 | US7790188 Antifungal protein and usage thereof |
| 09/07/2010 | US7790174 G-CSF polypeptides and uses thereof |
| 09/07/2010 | US7790171 Vircidal agent for treatment of multidrug-resistant human immunodeficiency viral infections |
| 09/07/2010 | US7790166 Anti-CD40 antibodies capable of blocking B-cell activation |
| 09/07/2010 | US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 09/07/2010 | US7790161 GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 09/07/2010 | US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases |
| 09/07/2010 | US7790157 Methods of modulating CARK protein activity |
| 09/07/2010 | US7790154 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 09/07/2010 | US7790153 Method of treating rheumatoid arthritis using orally administered type one interferons |
| 09/07/2010 | US7790152 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity |
| 09/07/2010 | US7790145 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/07/2010 | US7789841 Method and apparatus for connective tissue treatment |
| 09/07/2010 | CA2453112C New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls |
| 09/07/2010 | CA2450871C Assay for identifying inhibitors of hiv rt dimerization |
| 09/07/2010 | CA2405724C Substance p analogs for the treatment of cancer |
| 09/07/2010 | CA2368814C Use of glucosylceramide synthesis inhibitors in therapy |
| 09/07/2010 | CA2277999C The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 09/07/2010 | CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 09/07/2010 | CA2226177C Analogs of parathyroid hormone |
| 09/07/2010 | CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
| 09/05/2010 | CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation |
| 09/02/2010 | WO2010099537A1 Soft protease inhibitors, and pro-soft forms thereof |
| 09/02/2010 | WO2010099515A2 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 09/02/2010 | WO2010099510A2 Amino acid-based compounds, their methods of use, and methods of screening |
| 09/02/2010 | WO2010099477A2 Polypeptide structural motifs associated with cell signaling activity |
| 09/02/2010 | WO2010099436A1 Methods of treating retinitis pigmentosa |
| 09/02/2010 | WO2010099234A1 Use of guanylyl cyclase c agonists to suppress appetite |
| 09/02/2010 | WO2010099219A2 Designer ligands of tgf-beta superfamily |
| 09/02/2010 | WO2010099139A2 Combination anti-cancer therapy |
| 09/02/2010 | WO2010099003A2 Compositions and methods for visualizing and eliminating cancer stem cells |
| 09/02/2010 | WO2010098929A1 Drug delivery management systems and methods |
| 09/02/2010 | WO2010098781A1 Sphingosine 1-phosphate antagonism |
| 09/02/2010 | WO2010098503A1 Therapeutic agent for interstitial pneumonia |
| 09/02/2010 | WO2010098475A1 Agent for prevention and treatment of eating disorders |
| 09/02/2010 | WO2010098421A1 Recombinant human bone morphogenetic protein having improved storage stability |
| 09/02/2010 | WO2010098265A1 Polymeric micelle containing proteasome inhibitor |
| 09/02/2010 | WO2010097788A2 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 09/02/2010 | WO2010097720A1 Use of a fragment of rasgap peptide in the treatment or prevention of metastasis |
| 09/02/2010 | WO2010097012A1 ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| 09/02/2010 | WO2010081152A3 Keloid derived precursor cells and its applications of use thereof |
| 09/02/2010 | WO2010065524A3 Methods and compositions for the treatment of fluid retention disorders |
| 09/02/2010 | WO2010034779A3 Composition and method for treatment of preterm labor |
| 09/02/2010 | WO2010029546A3 Compositions and methods for treating s.pneumoniae infection |
| 09/02/2010 | WO2009089062A8 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders |
| 09/02/2010 | WO2009074797A8 Methods for inhibiting scarring |
| 09/02/2010 | WO2007022041A3 Mutations and polymorphisms of hdac3 |
| 09/02/2010 | WO2005043118A3 Drug discovery method |
| 09/02/2010 | US20100223685 Il-21 receptor knockout animal and methods of use thereof |
| 09/02/2010 | US20100223682 Casein and methods of use thereof |
| 09/02/2010 | US20100222875 Method for forming a porous stent coating |
| 09/02/2010 | US20100222557 Cytokine zalpha11ligand antibodies |
| 09/02/2010 | US20100222550 Compstatin analogs with improved activity |
| 09/02/2010 | US20100222438 Methods compositions and article of manufacture for modulating bone growth |
| 09/02/2010 | US20100222419 Method to inhibit cell growth using oligonucleotides |
| 09/02/2010 | US20100222283 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal desease |
| 09/02/2010 | US20100222282 Method of diagnosis and method of treatment |
| 09/02/2010 | US20100222281 Delivery of hydrophilic drugs |
| 09/02/2010 | US20100222280 PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1) |
| 09/02/2010 | US20100222279 Composition for animal consumption and method for reducing map kinase activity |
| 09/02/2010 | US20100222278 Use of leptin for the prevention of excess body weight and composition containing leptin |
| 09/02/2010 | US20100222277 Regulation of Food Preference Using GLP-1 Agonists |
| 09/02/2010 | US20100222276 protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications |
| 09/02/2010 | US20100222275 Therapeutic agent for vitiligo and method of accelerating pigmentation |
| 09/02/2010 | US20100222274 Glycosylation-deficient hepatocyte growth factor |
| 09/02/2010 | US20100222272 Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders |
| 09/02/2010 | US20100222271 Formulation to Improve Gastrointestinal Function |
| 09/02/2010 | US20100222270 Heterocyclic compounds as crth2 receptor antagonists |
| 09/02/2010 | US20100222269 Improved derivatives of amylin |
| 09/02/2010 | US20100222268 Antibiotic peptides |
| 09/02/2010 | US20100222267 Recombinant transferrin mutants |
| 09/02/2010 | US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 09/02/2010 | US20100222265 Heparin binding epidermal growth factor (hb-egf) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation |